Selective capture of prostatic basal cells and secretory epithelial cells for proteomic and genomic analysis

Urologic Oncology: Seminars and Original Investigations

Volumn 22, Issue 4, 2004, Pages 329-336

  Diaz, Jose I ^a   Cazares, Lisa H ^a   Corica, Alberto ^a   John Semmes, O ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Laser capture microdissection; Prostate cancer; Proteomics

Indexed keywords

RNA;

BASAL CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL TRANSFORMATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RNA ANALYSIS; TIME OF FLIGHT MASS SPECTROMETRY;

CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; IMMUNOASSAY; LASERS; MALE; MASS SPECTROMETRY; MICRODISSECTION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; RNA; SIGNAL TRANSDUCTION;

EID: 3342986727     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2004.04.010     Document Type: Conference Paper

References (22)

1. Robinson E.J., Neal D.E., Collins A.T. Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate. 37:1998;149-160
2. Mirosevich J., Bentel J.M., Zeps N., Redmond S.L., D'Antuono M.F., Dawkins H.J. Androgen receptor expression of proliferating basal and luminal cells in adult murine ventral prostate. J Endocrinol. 162:1999;341-350
3. Harper M.E., Glynne-Jones E., Goddard L., Mathews P., Nicholson R.I. Expression of androgen receptor and growth factors in premalignant lesions of the prostate. J Pathol. 186:1998;169-177
4. El-Alfy M., Pelletier G., Hermo L.S., Labrie F. Unique features of the basal cells of human prostate epithelium. Microsc Res Tech. 51:2000;436-446
5. Bonkhoff H., Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth a stem cell model. Prostate. 28:1996;98-106
6. Daliani D., Papandreou C.N. Markers of androgen-independent progression of prostatic carcinoma. Semin Oncol. 26:1999;399-406
7. Alcaraz A., Barranco M.A., Corral J.M., et al. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer. Prostate. 47:2001;29-35
8. Fromont G., Joulin V., Chantrel-Groussard K., et al. Allelic losses in localized prostate cancer association with prognostic factors. J Urol. 170:2003;1394-1397
9. Bostwick D.G., Pacelli A., Lopez-Beltran A. Ultrastructure of prostatic intraepithelial neoplasia. Prostate. 33:1997;32-37
10. Best C.J., Emmert-Buck M.R. Molecular profiling of tissue samples using laser capture microdissection. Expert Rev Mol Diagn. 1:2001;53-60
11. Ornstein D.K., Gillespie J.W., Paweletz C.P., et al. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis. 21:2000;2235-2242
12. Cazares L.H., Adam B.L., Ward M.D., et al. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res. 8:2002;2541-2552
13. Fend F., Emmert-Buck M.R., Chuaqui R., Cole K., Lee J., Liotta L.A., Raffeld M. Immuno-LCM laser capture microdissection of immunostained frozen sections for mRNA analysis. Am J Pathol. 154:1999;61-66
14. Emmert-Buck M.R., Bonner R.F., Smith P.D., Chuaqui R.F., Zhuang Z., Goldstein S.R. Laser capture microdissection. Science. 274:1996;998-1001
15. Munger K. Disruption of oncogene/tumor suppressor networks during human carcinogenesis. Cancer Invest. 20:2002;71-81
16. Qian J., Jenkins R.B., Bostwick D.G. Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Eur Urol. 35:1999;479-483
17. Park S., Shinohara K., Grossfeld G.D., Carroll P.R. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol. 165:2001;1409-1414
18. Kollermann J., Helpap B. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor Flk-1 in benign, premalignant, and malignant prostate tissue. Am J Clin Pathol. 116:2001;115-121
19. Ropiquet F., Giri D., Kwabi-Addo B., Mansukhani A., Ittmann M. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer. Cancer Res. 60:2000;4245-4250
20. Honn K.V., Aref A., Chen Y.Q., et al. Prostate Cancer - old problems and new approaches. (Part II diagnostic and prognostic markers, pathology and biological aspects). Pathol Oncol Res. 2:1996;191-211
21. Arrizabalaga Moreno M., Garcia Gonzalez J.I., Mora Durvan M., et al. Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis. Actas Urol Esp. 21:1997;724-736
22. Bonkhoff H. Role of the basal cells in premalignant changes of the human prostate a stem cell concept for the development of prostate cancer. Eur Urol. 30:1996;201-205